Latest Lead News

Develop Global reports strong September quarter progress with Woodlawn mine ramping up on schedule and Sulphur Springs DFS doubling projected cashflow to A$1.5 billion. A major mining services contract extension further bolsters the company’s growth outlook.

Australian Critical Minerals has completed a strategic acquisition of Circuit Resources, adding six multi-commodity projects in Peru and initiating exploration activities with drilling planned for late 2025.

Boab Metals has secured key environmental approvals and launched a $50 million capital raise to advance its Sorby Hills Lead-Silver-Zinc Project, marking a pivotal step toward production.

Kingfisher Mining secures shareholder approval for NSW tenement acquisition and accelerates exploration at Copper Blow and Mick Well REE projects, backed by a solid $2.35 million cash position.

Taruga Minerals has identified promising gold and base metal anomalies at its Thowagee South project in Western Australia, supported by new geophysical and geochemical data. These findings set the stage for refined exploration and potential future drilling.

EMVision Medical Devices has expanded its pivotal clinical trial sites, secured a $3 million government grant, and raised $14 million through placement and share purchase plan, positioning itself strongly for upcoming regulatory submissions and commercialisation.

Altech Batteries has successfully completed rigorous destructive safety tests on its Sodium-Nickel-Chloride battery technology, demonstrating exceptional resilience and intrinsic safety under extreme conditions.

Great Western Exploration has identified a significant gravity anomaly at its Oval Copper-Gold Targets, suggesting a large Volcanic Hosted Massive Sulphide system akin to the nearby DeGrussa deposit, with drilling plans advancing alongside promising developments at Juggernaut and Lake Way.

Restaurant Brands New Zealand’s Independent Directors unanimously recommend shareholders accept Finaccess Restauración’s NZ$5.05 per share takeover offer, citing significant premium and risk mitigation despite the offer being below assessed valuation.

ikeGPS has reported a robust first half of FY26 with subscription revenue soaring 47%, a successful A$24 million capital raise, and inclusion in the ASX All Ordinaries Index, underscoring its expanding footprint in the US grid modernization market.

Brazilian Critical Minerals has reported exceptional results from its in-situ recovery trials at the Ema rare earth project, achieving rare earth concentrations far exceeding in-situ grades and securing strong local government backing.

Cambium Bio has locked in a significant R&D tax rebate and forged three strategic partnerships, underpinning its Phase 3 clinical trials for its lead ophthalmology biologic. The company’s recent capital raise further strengthens its runway as it prepares for pivotal trial milestones.